CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction
The Company is seeking strategic opportunities to advance the development of this program
SAN DIEGO, March 23, 2023 /PRNewswire/ — CV Sciences, Inc.
(OTCQB:CVSI) (the “Company”, “CV Sciences”, “o…